Antifibrotic effects of low dose SGLT2 Inhibition with empagliflozin in comparison to Ang II receptor blockade with telmisartan in 5/6 nephrectomised rats on high salt diet

Shufei Zeng, Berthold Hocher, Chang Chu et al.|Biomedicine & Pharmacotherapy|2021

Cited by 37